Health insurers rallied sharply in early trading Tuesday after final Medicare Advantage reimbursement rates for 2027 came in better than expected, with the sector posting its strongest single-day performance in over three months.

Market Context

The S&P 500 Health Care sector index rose 2.3% in morning trading, outpacing the broader market's 0.4% gain. The Centers for Medicare and Medicaid Services released final rates late Monday that showed a weighted average increase of 4.5% for Medicare Advantage plans, above the 3.8% that analysts had projected in their pre-release models.

Analysis

The rate adjustment represents a significant win for insurers after months of uncertainty around reimbursement levels. Analysts had feared the CMS would implement deeper cuts following a period of elevated utilization in 2025 and early 2026. The final rates instead reflected adjustments that accounted for demographic changes and chronic condition management, rather than the aggressive cost containment some had anticipated. Institutional investors, who had been underweighting the group heading into the announcement, began covering shorts and adding positions in early trading.

UnitedHealth Group led the advance, up 4.2% to $542.30. Humana gained 5.8%, trading at $298.45. Elevance Health added 3.9% to $398.20, while Cigna rose 2.7% to $312.80. The gains were broadly distributed across the Medicare Advantage-focused insurers, with Centene and Molina Healthcare also posting solid increases.

Key Numbers

- UnitedHealth Group shares rose 4.2% to $542.30 in early trading

- Humana gained 5.8%, trading at $298.45

- Elevance Health added 3.9% to $398.20

- Cigna rose 2.7% to $312.80

- Medicare Advantage weighted average rate increase: 4.5% vs. 3.8% analyst projection

- S&P 500 Health Care sector up 2.3% in morning trading

What to Watch

Traders will now focus on second-quarter earnings reports beginning next month, where insurers are expected to detail enrollment trends and medical loss ratios. The favorable rate environment could support margin expansion in the Medicare Advantage business, though analysts note that utilization trends remain mixed. The next CMS notice for 2028 rates is expected in early fall, which could become a new catalyst for the group.

The sector's relative strength will also depend on broader market conditions, particularly given ongoing discussions about federal spending and health care policy priorities in Congress. Options activity showed elevated call buying across the group, with September expiry calls on UnitedHealth seeing unusual volume.